Zituvio Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Zituvio
J
- J-Cof DHC (brompheniramine / dihydrocodeine / pseudoephedrine)
- J-Max (guaifenesin / phenylephrine)
- J-Tan D (brompheniramine / phenylephrine)
- J-Tan D HC (brompheniramine / hydrocodone / pseudoephedrine)
- J-Tan D SR (brompheniramine / phenylephrine)
- J-TanD PD (brompheniramine / pseudoephedrine)
- Jaimiess (ethinyl estradiol / levonorgestrel)
- Jasmiel (drospirenone / ethinyl estradiol)
- JayCof-HC (chlorpheniramine / hydrocodone / pseudoephedrine)
- Jaypirca (pirtobrutinib)
- Jencycla (norethindrone)
- Jenest (ethinyl estradiol / norethindrone)
- Jevantique (ethinyl estradiol / norethindrone)
- Jevantique Lo (ethinyl estradiol / norethindrone)
- Jinteli (ethinyl estradiol / norethindrone)
- Jolessa (ethinyl estradiol / levonorgestrel)
- Jolivette (norethindrone)
- Joyeaux (ethinyl estradiol / levonorgestrel)
- Juleber (desogestrel / ethinyl estradiol)
- Julie (levonorgestrel)
- Junel 1.5 / 30 (ethinyl estradiol / norethindrone)
- Junel 1 / 20 (ethinyl estradiol / norethindrone)
- Junel Fe 1.5 / 30 (ethinyl estradiol / norethindrone)
- Junel Fe 1 / 20 (ethinyl estradiol / norethindrone)
- Junel Fe 24 (ethinyl estradiol / norethindrone)
- Juulissa Pharmapak (triamcinolone topical)
- Juxtapid (lomitapide)
More about Zituvio (sitagliptin)
- Zituvio consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dipeptidyl peptidase 4 inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.